EcoDrugPlus

Tubulin Beta 3 Class Iii

Ensembl ID : ENSJJAG00000016752
Gene Symbol: TUBB3
3 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSJJAG00000001103
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSJJAG00000021854
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSJJAG00000009769
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSJJAG00000024145
Gene Symbol: TUBB
3 Cross references
87 Possible Orthologues:

Tubulin, Alpha 1a

Ensembl ID : ENSJJAG00000010205
Gene Symbol: TUBA1A
1 Cross references
126 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSJJAG00000012331
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Type-1 Angiotensin Ii Receptor

Ensembl ID : ENSJJAG00000013602
Gene Symbol: LOC101596637
2 Cross references
178 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSJJAG00000005553
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSJJAG00000012231
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSJJAG00000020250
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSJJAG00000020351
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).